Viewing Study NCT06514157


Ignite Creation Date: 2025-12-24 @ 6:41 PM
Ignite Modification Date: 2026-03-29 @ 5:07 PM
Study NCT ID: NCT06514157
Status: COMPLETED
Last Update Posted: 2025-08-26
First Post: 2024-05-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants.
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module